Skip to content

Heather Madsen

Ms. Madsen is a director and the CEO of the issuer. at PIPr Therapeutics.

Raised on PIPr Therapeutics filings

$1.5M

of $2.5M offered across 1 Form D filing

Form D filings
1
Teammates
3
Last filing
Nov 12, 2025

Company

PIPr Therapeutics

Biotech · Durham, NC

Preclinical metalloprotease inhibitor drugs

Investors
3
Still open
$1M

PIPr Therapeutics filings

  • EquityFiled Nov 12, 2025Form D
    $1.5M/ $2.5M

Works with